A Randomized Controlled Pilot Study of Standardized Counselling and Cost-free Pharmacotherapy for Smoking Cessation Among Stroke and TIA Patients

NCT01404546 NA COMPLETED

This pilot study examined the effect of providing a 4 weeks of cost free quit smoking medications to smokers identified in a stroke prevention clinic who were interested in quitting smoking compared to providing a prescription for the medication only.

Details

Lead sponsor	Ottawa Heart Institute Research Corporation
Phase	NA
Status	COMPLETED
Enrolment	28
Start date	2008-08
Completion	2010-12

Conditions

• Stroke

Interventions

• cost free pharmacotherapy
• usual care

Primary outcomes

• smoking abstinence — 6-months
  The dependent variables of primary interest were measured at 26 weeks and included: (1) bio-chemically confirmed 7-day point prevalence abstinence; and (2) continuous abstinence since TQD. Participants who were not available for follow-up were considered smokers. At the 26 week follow-up, all patients who reported being abstinent from smoking had their smoking status confirmed by measurement of a CO sample. If any CO was \>10 ppm, the subject was considered a smoker.

Countries

Canada